José G. Merino
doi : 10.1212/WNL.0000000000013062
vol. 98 no. 2 51-52
Amy Brodtmann, Tobias Loetscher
doi : 10.1212/WNL.0000000000013051
vol. 98 no. 2 53-54
Sadhvi Saxena, Zafer Keser, Chris Rorden, Leonardo Bonilha, Julius Fridriksson, Alexandra Walker, Argye Elizabeth Hillis
doi : 10.1212/WNL.0000000000013050
vol. 98 no. 2 e107-e114
Hemispatial neglect is a heterogeneous and complex disorder that can be classified by frame of reference for “left” vs “right,” including viewer-centered neglect (VCN, affecting the contralesional side of the view), stimulus-centered neglect (SCN, affecting the contralesional side of the stimulus, irrespective of its location with respect to the viewer), or both. We investigated the effect of acute stroke lesions on the connectivity of neural networks that underlie VCN or SCN.
Teng Hwee Tan, Huili Zheng, Timothy Cheo, Jeremy Tey, Yu Yang Soon
doi : 10.1212/WNL.0000000000013058
vol. 98 no. 2 e115-e124
We aim to determine the risk of stroke and death within 30 days after stroke in nasopharyngeal cancer (NPC) survivors.
Johan Pallud, Gilles Huberfeld, Edouard Dezamis, Sophie Peeters, Alessandro Moiraghi, Martine Gavaret, Eléonore Guinard, Frédéric Dhermain, Pascale Varlet, Catherine Oppenheim, Fabrice Chrétien, Alexandre Roux, Marc Zanello
doi : 10.1212/WNL.0000000000013005
vol. 98 no. 2 e125-e140
The association between levetiracetam and survival with isocitrate dehydrogenase (IDH) wild-type glioblastomas is controversial. We investigated whether the duration of levetiracetam use during the standard chemoradiation protocol affects overall survival (OS) of patients with IDH wild-type glioblastoma.
Ezequiel Gleichgerrcht, Daniel L. Drane, Simon S. Keller, Kathryn A. Davis, Robert Gross, Jon T. Willie, Nigel Pedersen, Christophe de Bezenac, Jens Jensen, Ruben Kuzniecky, Leonardo Bonilha
doi : 10.1212/WNL.0000000000013033
vol. 98 no. 2 e141-e151
To determine the association between surgical lesions of distinct gray and white structures and connections with favorable postoperative seizure outcomes.
Remika Mito, David N. Vaughan, Mira Semmelroch, Alan Connelly, Graeme D. Jackson
doi : 10.1212/WNL.0000000000013006
vol. 98 no. 2 e152-e163
To identify white matter fiber tracts that exhibit structural abnormality in patients with bottom-of-sulcus dysplasia (BOSD) and investigate their association with seizure activity.
Melody Tunsubilege Asukile, Charle A. Viljoen, Edward Lee Pan, Roland Eastman, Lawrence Maskew Tucker
doi : 10.1212/WNL.0000000000012996
vol. 98 no. 2 e164-e173
To determine the effectiveness of a 6-month, interactive, multimodal, Web-based EEG teaching program (EEGonline) in improving EEG analysis and interpretation skills for neurologists, neurology residents, and technologists, particularly in resource-limited settings.
Bas C. Stunnenberg, Joost Berends, Robert C. Griggs, Jeffrey Statland, Gea Drost, Jane Nikles, Hans Groenewoud, Baziel G.M. van Engelen, Gert Jan van der Wilt, Joost Raaphorst
doi : 10.1212/WNL.0000000000012998
vol. 98 no. 2 e174-e185
To perform a systematic review of published N-of-1 trials (e.g., single patient crossover trials) in neurologic disorders, including an assessment of methodologic quality and reporting.
Cassandra C. Daisy, Speros Varinos, David R. Howell, Katherine Kaplan, Rebekah Mannix, William P. Meehan, Francis Wang, Brant Berkstresser, Richard S. Lee, John W. Froehlich, David Zurakowski, Marsha A. Moses
doi : 10.1212/WNL.0000000000013001
vol. 98 no. 2 e186-e198
Sport-related concussions affect millions of individuals across the United States each year, and current techniques to diagnose and monitor them rely largely on subjective measures. Our goal was to discover and validate objective, quantifiable noninvasive biomarkers with the potential to be used in sport-related concussion diagnosis.
Yi-Chu Liao, Fu-Pang Chang, Han-Wei Huang, Ting-Bing Chen, Ying-Tsen Chou, Shao-Lun Hsu, Kang-Yang Jih, Yi-Hong Liu, Cheng-Tsung Hsiao, Hiromi Fukukda, Takeshi Mizuguchi, Kon-Ping Lin, Chou-Ching K. Lin, Naomichi Matsumoto, Marina Kennerson, Yi-Chung Lee
doi : 10.1212/WNL.0000000000013008
vol. 98 no. 2 e199-e206
The GGC repeat expansion in the 5? untranslated region of NOTCH2NLC was recently identified as the cause of neuronal intranuclear inclusion disease (NIID), which may manifest with peripheral neuropathy. The aim of this study is to investigate its contribution to inherited neuropathy.
Lyell K. Jones, Robert A. Gross
doi : 10.1212/WNL.0000000000013064
vol. 98 no. 2 64
Tim Denison, Martha J. Morrell
doi : 10.1212/WNL.0000000000013061
vol. 98 no. 2 65-72
Neuromodulation devices are approved in the United States for the treatment of movement disorders, epilepsy, pain, and depression, and are used off-label for other neurologic indications. By 2035, advances in our understanding of neuroanatomical networks and in the mechanism of action of stimulation, coupled with developments in material science, miniaturization, energy storage, and delivery, will expand the use of neuromodulation devices. Neuromodulation approaches are flexible and modifiable. Stimulation can be targeted to a dysfunctional brain focus, region, or network, and can be delivered as a single treatment, continuously, according to a duty cycle, or in response to physiologic changes. Programming can be titrated and modified based on the clinical response or a physiologic biomarker. In addition to keeping pace with clinical and technological developments, neurologists in 2035 will need to navigate complex ethical and economic considerations to ensure access to neuromodulation technology for a rapidly expanding population of patients. This article provides an overview of systems in use today and those that are anticipated and highlights the opportunities and challenges for the future, some of which are technical, but most of which will be addressed by learning about brain networks, and from rapidly growing experience with neuromodulation devices.
Justin A. Sattin, Winston Chiong, Richard J. Bonnie, Matthew P. Kirschen, James A. Russell, on behalf of the Ethics, Law, and Humanities Committee, a joint committee of the American Academy of Neurology, American Neurological Association, and Child Neurology Society
doi : 10.1212/WNL.0000000000013040
vol. 98 no. 2 73-79
This position statement briefly reviews the principle of informed consent, the elements of decisional capacity, and how acute stroke may affect this capacity. It further reviews the role of surrogate decision-making, including advance directives, next of kin, physician orders for life-sustaining treatment, and guardianship. In some cases of acute stroke in which the patient lacks decisional capacity and no advance directives or surrogates are available, consent to treatment may be presumed. The document describes the rationale for this position and various considerations regarding its application to IV thrombolysis, neuroendovascular intervention, decompressive craniectomy, and pediatric stroke. The document also reviews consent issues in acute stroke research.
Kunqian Ji, Hong Ren, Xiuhe Zhao, Chuanzhu Yan
doi : 10.1212/WNL.0000000000013015
vol. 98 no. 2 80-81
Neel Fotedar, Junling Dong, Alexander Lewis, Michael Devereaux, Alessandro Serra
doi : 10.1212/WNL.0000000000012999
vol. 98 no. 2 82-87
Charlie Weige Zhao
doi : 10.1212/WNL.0000000000013004
vol. 98 no. 2 e207-e208
Diana J. Kim, Sina Marzoughi, Thalia S. Field
doi : 10.1212/WNL.0000000000013002
vol. 98 no. 2 e209-e210
Igor Vilela Brum, Guilherme Diogo Silva
doi : 10.1212/WNL.0000000000013007
vol. 98 no. 2 e211-e212
Aravind Ganesh, Steven Galetta
doi : 10.1212/WNL.0000000000013070
vol. 98 no. 2 88
Steven R. Brenner
doi : 10.1212/WNL.0000000000013072
vol. 98 no. 2 88-89
Tommaso Ballarini, Debora Melo van Lent, Michael Wagner
doi : 10.1212/WNL.0000000000013074
vol. 98 no. 2 89-90
آیا می خواهید مدیلیب را به صفحه اصلی خود اضافه کنید؟